Mdm2 selectively suppresses DNA damage arising from inhibition of topoisomerase II independent of p53.

Senturk, J C; Bohlman, S; Manfredi, J J

Senturk, J C; Bohlman, S; Manfredi, J J.

Affiliation

Senturk JC; Department of Oncological Sciences and Graduate School of Biological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Bohlman S; Department of Oncological Sciences and Graduate School of Biological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Manfredi JJ; Department of Oncological Sciences and Graduate School of Biological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Oncogene ; 36(44): 6085-6096, 2017 11 02.

Article in En | MEDLINE | ID: mdl-28692049

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteosarcoma / Tumor Suppressor Protein p53 / DNA Topoisomerases, Type II / Proto-Oncogene Proteins c-mdm2 Limits: Animals / Humans Language: En Journal: Oncogene Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2017 Document type: Article Affiliation country: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google